Glenmark Pharmaceuticals Ltd

News across the web »
Interact & exchange stock tips & market info »

MMB Messenger

Platinum Member

112820 Followers

MMB Messenger

Platinum Member

112820 Followers

MMB Messenger

Platinum Member

112820 Followers

Related News »
As per ORG IMS MAT March 2012 data, Glenmark has gained two rank, from 25th to 23rd. Further, its market share has increased in dermatology from 8.3% to 8.4%, cardiology 2.4% to 2.5% and respiratory from 1.2% to 2.7%. Glenmark Pharma has ...
May 25, 2012 at 15:13 | Source: equitybulls.com
Among frontline companies, all acute focused companies, including Glenmark Pharmaceuticals Ltd, Pfizer Ltd and GlaxoSmithKline Pharmaceuticals Ltd, significantly outperformed the industry because of strong recovery in segments such as anti-infective ...
May 23, 2012 at 17:17 | Source: Livemint.com
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
May 16, 2012 at 06:56 | Source: RTT News
has granted tentative approval for Glenmark Generics Inc's (GGI), a US based subsidiary of Glenmark Pharmaceuticals Ltd, zolmitriptan orally disintegrating tablets, the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2 ...
May 16, 2012 at 07:46 | Source: pharmabiz.com
The Glenmark Pharmaceuticals Ltd stock was trading at Rs.356.25, down by Rs.9.10 or 2.49%. The stock hit an intraday high of Rs.369.70 and low of Rs.352.65. The total traded quantity was 0.81 lakhs compared to 2 week average of 1.53 lakhs.
May 16, 2012 at 07:17 | Source: equitybulls.com
(Economic Times) * Mangalore Refinery and Petrochemicals Ltd confirmed it will cut crude imports ... (Business Standard) * Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several ...
May 25, 2012 at 03:18 | Source: Reuters